Abstract:Jinrui Zhang, 1 Huaicheng Wang, 1 Weilong Suo, 2 Zhizhou Li, 1 Chunxu Yang 3 1 Department of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, 130033, People's Republic of China; 2 Key Laboratory of Applied Chemistry and Nanotechnology at Universities of Jilin Province, Changchun University of Science and Technology, Changchun, 130022, People's Republic of China; 3 Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, People's Republic of China Correspondence: Zhizhou Li; Chunxu Yang Email ; Purpose: Radiotherapy (RT) is recommended as an extensive therapeutic regimen for cancer patients; however, cancer radio-resistance results from reduced oxygen levels (hypoxia) in the tumor microenvironment. Herein, we report a therapeutic strategy that greatly enhances the treatment effects of RT. Methods: Specifically, papaverine (ppv), an FDA-approved smooth muscle relaxant, was applied in the strategy. Ppv improved blood flow via vasodilation to deliver sufficient oxygen to the hypoxic solid tumor and further resulted in increased tumor penetration of the radiosensitizer, significantly enhancing the radiosensitization compared with no ppv treatment. Additionally, tantalum oxide nanospheres were cloaked in red blood cell membranes () to achieve greater biocompatibility, non-immunogenicity, and a longer circulation time. Results: As a high-Z element, tantalum provides localized dose enhancement and thereby boosts the efficacy of RT. Vasodilation, the oxygenation of cancer cells, and the improved accumulation and retention of in the tumor region were verified in vivo. Furthermore, compared with RT alone, the combined vasodilation and nanosphere camouflaging strategy more efficiently suppressed the growth of K7M2 tumors in mice. Conclusion: The results of this study suggest that the integration of and ppv has excellent potential for improving RT efficacy. Keywords: radiotherapy, hypoxia, tantalum oxide, papaverine, vessel vasodilation Because of radio-resistance, radiotherapy (RT) is limited as a palliative regimen for osteosarcoma cancer and as a local control. 1,2 At least one factor accounts for radio-resistance: aberrant angiogenesis, which is due to the excessive proliferation of tumors cells, 3 and the resulting lack of oxygen stabilizes the DNA double-strand breaks. 4–6 In this respect, methods of relieving hypoxia are attracting attention for improving the effectiveness of RT. 7–10 Although, overall, the mechanisms of resistance to RT are complex and remain unclear. In order to avoid acute or chronic radiation effects, it is crucial that we identify a therapeutic strategy to enhance the deposition of radiation energy at the tumor target and to alleviate side effects in adjacent tissues or vulnerable organs. 11 To promote the sensitivity of cancer cells to radiation, the use of elements with high atomic numbers for generating photo/auger electrons has been recommended. 12 For instance, gold, 13,14 bismuth, 15,16 platinum, 17 and tantalum 18,19 nanoplatforms have been assessed as radiosensitizers. Despite substantial recent advances, difficulties with enhancing radiosensitization remain. Important issues include increasing the ability of the radiosensitizer to penetrate the tumor and reach all viable cells and assisting the radiosensitizer to escape clearance by the reticuloendothelial system (RES). 5,20–22 Nevertheless, most tumors tend to "outgrow" the blood supply as a result of rapid cellular proliferation. To meet the demand of cancerous cells for nutrition and oxygen, angiogenesis is stimulated and new primitive blood vessels are formed, resulting in large interstitial spaces among the vessels, which often results in cancer cells being distant from blood vessels. Within tumor interstitial spaces, the dense extracellular matrix comprises a hydrophilic gel with a high ratio of collagen and elastic fiber, proteoglycans, and glycosaminoglycan, and it has an elevated fluid pressure because of heterogeneity. 23,24 Meanwhile, the primitive tumor vasculature is morphologically and functionally abnormal and causes disrupted blood flow. The large interstitial space, dense extracellular matrix, and abnormal angiogenesis in tumors decrease the nanoparticle diffusion rate. Meanwhile, these factors increase the distance nanoparticles have to travel, and hinder their penetration into solid tumors, causing intratumoral diffusion resistance which cause uneven distribution of radiosensiti -Abstract Truncated-

Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism

The Biological Relevance of Papaverine in Cancer Cells

Penetration Enhancing of an Erythrocyte-Mimicking Nanoplatform via Papaverine for Radiosensitization

Unraveling the Nephroprotective Potential of Papaverine against Cisplatin Toxicity through Mitigating Oxidative Stress and Inflammation: Insights from In Silico, In Vitro, and In Vivo Investigations

Papaverine Enhances the Oncolytic Effects of Newcastle Disease Virus on Breast Cancer In Vitro and In Vivo

Improved Tumor Control Following Radiosensitization with Ultrasound-Sensitive Oxygen Microbubbles and Tumor Mitochondrial Respiration Inhibitors in a Preclinical Model of Head and Neck Cancer

Defeating Relapsed and Refractory Malignancies Through a Nano-Enabled Mitochondria-Mediated Respiratory Inhibition and Damage Pathway

Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia in murine tumor models

Inhibition of Phosphoglycerate Dehydrogenase Radiosensitizes Human Colorectal Cancer Cells under Hypoxic Conditions

Antiproliferative effect of the isoquinoline alkaloid papaverine in hepatocarcinoma HepG-2 cells--inhibition of telomerase and induction of senescence

Overcome radiation resistance in hypoxic cancer cells by inhibition of glycolysis

Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization

Papuamine Inhibits Viability of Non-small Cell Lung Cancer Cells by Inducing Mitochondrial Dysfunction

Abstract 5416: Purinergic P2Y6 receptor antagonists as potential anti tumor agents

Mitochondrial Respiration Inhibition Suppresses Papillary Thyroid Carcinoma Via PI3K/Akt/FoxO1/Cyclin D1 Pathway

Characterizing OXPHOS inhibitor-mediated alleviation of hypoxia using high-throughput live cell-imaging

Radiation-/hypoxia-induced Solid Tumor Metastasis and Regrowth Inhibited by Hypoxia-Specific Upconversion Nanoradiosensitizer

Targeting Mitochondrial Metabolism to Reverse Radioresistance: An Alternative to Glucose Metabolism

Inhibition of autophagy as a strategy to augment radiosensitization by the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235

Inhibition Of Mitochondrial Respiration - A Novel Strategy To Enhance Drug-Induced Apoptosis In Human Leukemia Cells By A Reactive Oxygen Species-Mediated Mechanism

Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas